CAR T-Cell Therapy Makes its Mark in CLL

David L. Porter, MD, discusses CAR T-cell therapy in chronic lymphocytic leukemia and looks towards improvements and unmet needs that remain.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,University Of Pennsylvania ,Jodi Fisher Horowitz ,Davidl Porter ,Cell Therapy ,Jodi Fisher Horowitz Professor ,Leukemia Care Excellence ,Penn Medicine ,Stem Cell Transplant ,Cellular Therapy Symposium ,